Forian (NASDAQ:FORA) Receives "Buy" Rating from Roth Mkm

Forian (NASDAQ:FORA - Get Free Report)'s stock had its "buy" rating reiterated by analysts at Roth Mkm in a research note issued to investors on Thursday, Benzinga reports. They presently have a $5.00 price target on the stock. Roth Mkm's price target suggests a potential upside of 64.47% from the stock's current price.

Separately, Roth Capital restated a "buy" rating on shares of Forian in a research report on Wednesday, December 20th.

View Our Latest Stock Report on FORA

Forian Price Performance

Shares of FORA traded down $0.02 during midday trading on Thursday, reaching $3.04. 6,211 shares of the stock were exchanged, compared to its average volume of 27,652. The business's 50-day moving average price is $2.95 and its 200 day moving average price is $2.70. Forian has a twelve month low of $1.85 and a twelve month high of $4.15. The company has a market capitalization of $94.64 million, a price-to-earnings ratio of 9.21 and a beta of 1.03.

Institutional Investors Weigh In On Forian

Several institutional investors have recently modified their holdings of the company. Pathstone Family Office LLC purchased a new stake in Forian in the 3rd quarter valued at approximately $39,000. Jane Street Group LLC acquired a new stake in Forian in the 1st quarter valued at $41,000. Independent Advisor Alliance increased its holdings in Forian by 21.2% in the 3rd quarter. Independent Advisor Alliance now owns 22,491 shares of the company's stock valued at $50,000 after purchasing an additional 3,936 shares in the last quarter. Renaissance Technologies LLC purchased a new position in Forian in the 2nd quarter valued at about $59,000. Finally, Raymond James Financial Services Advisors Inc. boosted its position in Forian by 11.4% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 40,000 shares of the company's stock valued at $89,000 after buying an additional 4,092 shares during the last quarter. Hedge funds and other institutional investors own 19.25% of the company's stock.


About Forian

(Get Free Report)

Forian Inc provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other.

Recommended Stories

Should you invest $1,000 in Forian right now?

Before you consider Forian, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.

While Forian currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: